Yoshitaka Kihira

Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid

Hiroto Hatakeyama, Hidetaka Akita, Kentaro Kogure et al. · Gene Therapy · 2006 · 393 citations

Cancer Therapy, Nanomedicine, Cell-based Drug Delivery +7

Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes

Yasumasa Ikeda, Soichiro Tajima, Yuki Izawa‐Ishizawa et al. · PLoS ONE · 2012 · 136 citations · Full text

Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice

Soichiro Tajima, Yasumasa Ikeda, Kaori Sawada et al. · American Journal of Physiology-Endocrinology and Metabolism · 2011 · 107 citations

Metabolic Disorder, Iron Metabolism, Lipid Peroxidation +17

Iron Chelation by Deferoxamine Prevents Renal Interstitial Fibrosis in Mice with Unilateral Ureteral Obstruction

Yasumasa Ikeda, Iori Ozono, Soichiro Tajima et al. · PLoS ONE · 2014 · 93 citations · Full text

Deferoxamine promotes angiogenesis via the activation of vascular endothelial cell function

Yasumasa Ikeda, Soichiro Tajima, Sumiko Yoshida et al. · Atherosclerosis · 2011 · 77 citations

Endothelial Cell Pathobiology, Developmental Biology, Angiogenesis +6